Robert A. Mello
...Robert A. Mello
.Robert A. Mello joined IRIS in April 2000 and is Corporate Vice President and President of the IRIS Sample Processing division.Mr. Mello has 27 years of experience in medical device manufacturing, service, marketing and engineering.From 1988 to April 2000, he was an executive with bioMerieux, which designs, manufactures and markets medical instruments and consumables for immunodiagnostic and microbiology laboratories worldwide.Most recently, Mr. Mello was bioMerieux's Vice President of Operations at their facility in the Boston area.Before that, he was Vice President of Disposables Manufacturing at bioMerieux's clinical microbiology facility.Prior to joining bioMerieux, he held senior management positions with Medical & Scientific Designs and Ortho Diagnostics Inc., a division of Johnson & Johnson.Mr. Mello holds degrees in both Electrical Engineering and Business Management and has global experience in the IVD market.
Section 16(A) Beneficial Ownership Reporting Compliance
Under Section 16(a) of the Securities Exchange Act of 1934, our directors and officers and our significant stockholders (defined by statute as stockholders beneficially owning more than 10% of our common stock) are required to file with the Securities and Exchange Commission
and IRIS reports of ownership, and changes in ownership, of common stock.Based solely on a review of the reports received by us, we believe that, during the year ended December 31, 2006, all of our officers, directors and significant stockholders complied with all applicable filing requirements under Section 16(a), except one Statement of Changes in Beneficial Ownership on Form 4, reporting one transaction, was filed late by each of Mr. Alfano, Mr. Mello
, Mr. Garcia and Mr. Yi, relating to restricted stock awards.